• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Feuille James disposed of 23,766,254 shares, acquired 23,766,254 shares and converted options into 23,766,254 shares (SEC Form 4)

    6/13/25 7:41:34 PM ET
    $CHYM
    Finance: Consumer Services
    Finance
    Get the next $CHYM alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Feuille James

    (Last) (First) (Middle)
    C/O CHIME FINANCIAL, INC.
    101 CALIFORNIA STREET, SUITE 500

    (Street)
    SAN FRANCISCO CA 94111

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Chime Financial, Inc. [ CHYM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/13/2025 C 23,766,254 A (1)(2)(3) 23,766,254(4) I See footnote(5)
    Common Stock 06/13/2025 J(6) 23,766,254 D (6) 0 I See footnote(5)
    Class A Common Stock 06/13/2025 J(6) 23,766,254 A (6) 23,766,254(4) I See footnote(5)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Series A Preferred Stock (1) 06/13/2025 C 16,166,706 (1) (1) Common Stock 16,310,624 (1) 0 I See footnote(5)(7)
    Series A-2 Preferred Stock (2) 06/13/2025 C 5,069,680 (2) (2) Common Stock 5,069,680 (2) 0 I See footnote(5)(8)
    Series B Preferred Stock (3) 06/13/2025 C 2,385,950 (3) (3) Common Stock 2,385,950 (3) 0 I See footnote(5)(9)
    Explanation of Responses:
    1. Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and had no expiration date.
    2. Each share of Series A-2 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.
    3. Each share of Series B Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date.
    4. These shares are held as follows: (i) 7,221,106 shares held by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 10,782,501 shares held by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 4,620,340 shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 1,142,307 shares held by Crosslink Bayview VII, LLC ("CB VII").
    5. The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
    6. Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO.
    7. These shares were held as follows: (i) 6,555,280 shares held by CO VI; (ii) 6,263,780 shares held by CV VII; (iii) 2,684,056 shares held by CV VII-B; and (iv) 663,590 shares held by CB VII.
    8. These shares were held as follows: (i) 2,908,030 shares held by CV VII; (ii) 1,246,100 shares held by CV VII-B; (iii) 607,470 shares held by CO VI; and (iv) 308,080 shares held by CB VII.
    9. These shares were held as follows: (i) 1,554,930 shares held by CV VII; (ii) 666,290 shares held by CV VII-B; and (iii) 164,730 shares held by CB VII.
    /s/ Theresa Bloom. by power of attorney 06/13/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CHYM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHYM

    DatePrice TargetRatingAnalyst
    More analyst ratings